New York City-based NYU Langone Health reported an operating income of $165.8 million (3.7% operating margin) in the third quarter of 2026, compared to an operating income of $156.8 million (3.9% margin) during the same period last year, according to its July 27 financial report.
NYU Langone Health reported total operating revenue of $4.4 billion for the three months ended May 31, up from $4 billion during the same period last year. Net patient service revenue was $3.4 billion, up from $3.1 billion. Pharmacy revenue totaled $426.3 million, up from $320.3 million.
Total operating expenses were $4.3 billion in Q3 2026, up from $3.9 billion during the same period last year. Salaries, wages and employee benefits totaled $2.6 billion, up from $2.4 billion. Supplies and other expenses totaled $1.4 billion, up from $1.2 billion.
Within the health system, NYU Langone Hospitals recorded an operating income of $258.2 million (8.2% margin) in Q3 2026, compared to $240.1 million (8.6% margin) during the same period last year. The NYU Grossman Schools of Medicine recorded an operating loss of $92.5 million (-5% margin), compared to an $83.6 million loss (-5% margin) during the same period last year.
For the nine months ended May 31, the health system recorded an operating income of $437.7 million (3.4% margin), up from $362.6 million (3.2% margin) during the same period last year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.